Rule GIPI/MDIC No. 8, of October 18, 2023, comprising an action plan for the next biennium involving the Brazilian Patent and Trademark Office, was...
OUR TEAM
Samantha Salim
Patent Specialist
Samantha has been working with Intellectual Property since 2010 and joined Daniel Law as a patent specialist in 2015. Her expertise covers all aspects related to the prosecution of patent applications at the Brazilian PTO and the National Agency for Sanitary Surveillance (ANVISA), with particular emphasis on patent applications in the chemical, petrochemical, and pharmaceutical field.
Samantha acts in the preparation of reports and compliance/contestation of technical opinions issued by the Brazilian PTO and ANVISA, subsidies to the technical examination, prior art searches, FTO’s, equivalent searches for BR applications, drafting patent applications, and in the preparation of technical opinions to support case laws. She has full knowledge of the normative instructions, examination guidelines, Brazilian IP law and the main intellectual property treaties.
Practice Areas
Patents
Pharma
Chemistry
Pharma
Chemistry
Education
Graduated in Intellectual Property Law from the Pontifical Catholic University of Rio de Janeiro – PUC-Rio, 2016, with the dissertation “Selection invention: a comparative study encompassing concepts, patentability criteria and case law on this theme”;
Degree in Chemical Engineering from the Fluminense Federal University (UFF) in 2012, with the dissertation “Trend analysis to improve delayed coking units”.
Degree in Chemical Engineering from the Fluminense Federal University (UFF) in 2012, with the dissertation “Trend analysis to improve delayed coking units”.
Affiliations, Commissions and Collegiate
Languages
Portuguese and English.
Articles
Insights for patent protection of car-t cells-related technologies in Brazil
Chimeric antigen receptor (CAR) T-cell therapy is a personalised cancer treatment that is gaining greater visibility and enthusiasm as research...
ANVISA prohibits importation of the Cannabis plant in natura
Through Technical Note No. 35/2023, ANVISA (the Brazilian National Agency for Sanitary Surveillance – the Brazilian FDA) prohibited the importation...
Cannabis for Therapeutic Purposes in Brazil: Recent Developments and Future Perspectives
It is not news that cannabis-based medicines have been used for millennia around the world in the treatment of conditions and diseases such as...
Brazilian PTO publishes the final version of the guidelines for examining inventions related to transgenic plants, especially elite events
As previously reported, in June of last year, the Brazilian PTO opened a public consultation on the technical note regarding patentability...
Brazilian PTO opens Public Consultation on Technical Note BRPTO/CPAPD #01/2022, regarding the patentability of inventions associated with transgenic plants, especially elite events
On June 01, 2022, the Brazilian PTO announced, through Official Gazette #103, that the Public Consultation on Technical Note BRPTO/CPAPD #01/2022 is...
Public Consultation – Brazilian PTO’s technical note regarding the patentability of inventions associated with transgenic plants is temporarily suspended
On April 19, 2022, the Brazilian PTO published in Industrial Property Journal #2676 the suspension of the applicability of the Technical Note...
Brazilian PTO clarifies patentability requirements for inventions related to transgenic plants, especially elite events
Background: Based on the provisions of Article 10 (IX) of the Brazilian IP Law # 9,279/96, natural living beings (animals and plants), in whole or...
New ordinances relating to the accelerated patent prosecution in Brazil come into force in early 2022
The Brazilian PTO published at the end of last year new ordinances # 53, 54 and 55, which regulate the accelerated patent prosecution of patent...
Ordinance PR # 56/2021: Brazilian PTO postpones obligation to submit Sequence Listing file in Standard ST.26 format to July 2022
On December 28, the Brazilian PTO published Ordinance PR # 56/2021, with new conditions for the submission of Sequence Listing files. The new...
The impacts of ending ANVISA’S participation in the examination of Brazilian patent applications
About a month after the publication of Law # 14,195/21, which revoked Article 229-C of the Brazilian IP Law, it is already possible to observe...
What to expect from the examination of cannabinoid patent applications after ruling out ANVISA’s interference
Brazilian law # 14,195/21 revoking Article 229-C of the Brazilian IP Law was recently sanctioned by the Presidency, leading to intense debate on how...
ANVISA Publishes Manuals for Examination and Prior Consent of Patent Applications
The Brazilian National Agency for Sanitary Surveillance (ANVISA) has published four manuals related to examination and prior consent with respect to...
ANVISA publishes manuals for examination and prior approval of patent applications
The National Agency for Sanitary Surveillance (ANVISA), the Brazilian FDA, published last Thursday (November 19, 2020) four manuals related to...
Brazil: FDA issues guidelines for examination and prior consent of patent applications
Rafael Salomão Romano and Samantha Salim of Daniel Law outline how the instructions will improve transparency and accountability in the Brazilian...
How to protect therapeutic methods in Brazil
Brazil’s patent law does not allow methods of treatment to be patented, but there are other means of getting protection, according to Kene Gallois...
PPH between BRPTO and UKIPO on Biotech and Telecom fields
The Brazilian Patent Office (BRPTO) published on July 24, 2018, Rule # 222/2018, which establishes the procedures related to the Patent Prosecution...
Rare diseases, Chikungunya and Zika are now possibilities for fast-track examination request
The Brazilian PTO published on May 9th, 2018 Rule # 217/2018, which modifies former Rule # 80/2013 related to the fast-track examination of patent...
BPTO extends the period for requesting priority examination under the PPH with the USPTO
n complement of Rule # 154 of December 21, 2015, the Brazilian PTO published today (January 30, 2018) Rule # 210/2018 of January 26, 2018, which...
Phase II of USPTO-BPTO PPH: new requirements and extension of the covered technical field
The Brazilian PTO published on May, 9th Rule # 218/2018, which establishes the second phase of the Patent Prosecution Highway (PPH) between the...
BRPTO’s establishes guidelines for examining chemical patent applications
The Brazilian PTO published in January 2nd Rule 208/2017, which provides guidelines for the examination of patent applications related to the...
BRPTO launched a public consultation inviting comments on chemical patents application
The Brazilian PTO published a draft guidelines for the examination of patent applications related to the chemical field (please find enclosed an...
BRPTO and ANVISA’s role regarding the examination of pharma patents application
On April 12, 2017, Brazilian PTO and ANVISA (Brazilian Health Surveillance Agency) signed the Joint Ordinance # 1/2017, which regulates the...
Bridging the great divide
Since 2001, the grant of pharmaceutical-related patent applications in Brazil has come to depend on a prior approval analysis by the Brazilian...
Selection invention in the pharmaceutical area: an overview of the BPTO and ANVISA’s legal opinions
A selection invention is one in which a single element or small segment within a broad known group is selected and claimed in an independent way,...